Left atrial thrombosis despite dabigatran therapy

Anil Pandit, Fayaz A. Hakim, Komandoor Srivathsan, John J. Lynch

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Dabigatran is a novel anticoagulation which has been approved as an alternative to warfarin therapy for non-valvular atrial fibrillation. Use of Dabigatran for approved indications as well as off label use has dramatically increased after Federal Drug Administration (FDA) approval. Our patient had left atrial thrombosis even after being on Dabigatran for more than one month which raises question about safety and efficacy of use of dabigatran around cardioversion and ablation..

Original languageEnglish (US)
Pages (from-to)31-32
Number of pages2
JournalJournal of Atrial Fibrillation
Volume6
Issue number2
StatePublished - Aug 1 2013

Fingerprint

Thrombosis
Off-Label Use
Drug Approval
Electric Countershock
Warfarin
Therapeutics
Atrial Fibrillation
Safety
Dabigatran

Keywords

  • Atrial fibrillation
  • Dabigatran
  • Left atrial thrombosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Pandit, A., Hakim, F. A., Srivathsan, K., & Lynch, J. J. (2013). Left atrial thrombosis despite dabigatran therapy. Journal of Atrial Fibrillation, 6(2), 31-32.

Left atrial thrombosis despite dabigatran therapy. / Pandit, Anil; Hakim, Fayaz A.; Srivathsan, Komandoor; Lynch, John J.

In: Journal of Atrial Fibrillation, Vol. 6, No. 2, 01.08.2013, p. 31-32.

Research output: Contribution to journalArticle

Pandit, A, Hakim, FA, Srivathsan, K & Lynch, JJ 2013, 'Left atrial thrombosis despite dabigatran therapy', Journal of Atrial Fibrillation, vol. 6, no. 2, pp. 31-32.
Pandit, Anil ; Hakim, Fayaz A. ; Srivathsan, Komandoor ; Lynch, John J. / Left atrial thrombosis despite dabigatran therapy. In: Journal of Atrial Fibrillation. 2013 ; Vol. 6, No. 2. pp. 31-32.
@article{9dc1196b1a7348beb158d6e50c1c950e,
title = "Left atrial thrombosis despite dabigatran therapy",
abstract = "Dabigatran is a novel anticoagulation which has been approved as an alternative to warfarin therapy for non-valvular atrial fibrillation. Use of Dabigatran for approved indications as well as off label use has dramatically increased after Federal Drug Administration (FDA) approval. Our patient had left atrial thrombosis even after being on Dabigatran for more than one month which raises question about safety and efficacy of use of dabigatran around cardioversion and ablation..",
keywords = "Atrial fibrillation, Dabigatran, Left atrial thrombosis",
author = "Anil Pandit and Hakim, {Fayaz A.} and Komandoor Srivathsan and Lynch, {John J.}",
year = "2013",
month = "8",
day = "1",
language = "English (US)",
volume = "6",
pages = "31--32",
journal = "Journal of Atrial Fibrillation",
issn = "1941-6911",
publisher = "Cardiofront, Inc.",
number = "2",

}

TY - JOUR

T1 - Left atrial thrombosis despite dabigatran therapy

AU - Pandit, Anil

AU - Hakim, Fayaz A.

AU - Srivathsan, Komandoor

AU - Lynch, John J.

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Dabigatran is a novel anticoagulation which has been approved as an alternative to warfarin therapy for non-valvular atrial fibrillation. Use of Dabigatran for approved indications as well as off label use has dramatically increased after Federal Drug Administration (FDA) approval. Our patient had left atrial thrombosis even after being on Dabigatran for more than one month which raises question about safety and efficacy of use of dabigatran around cardioversion and ablation..

AB - Dabigatran is a novel anticoagulation which has been approved as an alternative to warfarin therapy for non-valvular atrial fibrillation. Use of Dabigatran for approved indications as well as off label use has dramatically increased after Federal Drug Administration (FDA) approval. Our patient had left atrial thrombosis even after being on Dabigatran for more than one month which raises question about safety and efficacy of use of dabigatran around cardioversion and ablation..

KW - Atrial fibrillation

KW - Dabigatran

KW - Left atrial thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84883866536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883866536&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 31

EP - 32

JO - Journal of Atrial Fibrillation

JF - Journal of Atrial Fibrillation

SN - 1941-6911

IS - 2

ER -